Skip to main content
Signal8

Ros Matthew

SEC insider (Form 3/4/5 filer). CIK 0001673802. Director at Cogent Biosciences, Inc. (COGT) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in WALTHAM, MA.

Companies Ros Matthew has filed insider reports for

  • Cogent Biosciences, Inc. (COGT): Director
  • Verastem, Inc. (VSTM): Officer, Chief Operating Officer
Ros Matthew profile photo

Ros Matthew

CIK: 0001673802

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Cogent Biosciences, Inc. logo
COGT

Cogent Biosciences, Inc.

Director
Verastem, Inc. logo
VSTM

Verastem, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Cogent Biosciences, Inc. logo
    COGT

    Cogent Biosciences, Inc.

    Jun 9, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    17.9K shares-
  • Cogent Biosciences, Inc. logo
    COGT

    Cogent Biosciences, Inc.

    Jun 4, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    44.7K shares-
  • Verastem, Inc. logo
    VSTM

    Verastem, Inc.

    Apr 1, 2025
    Award
    Direct
    50K shares-

1-3 of 3